{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:09:50Z","timestamp":1648832990019},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11606-020-06567-7","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T22:02:52Z","timestamp":1611352972000},"page":"1490-1491","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza, Like COVID-19, Needs Randomized Trials"],"prefix":"10.1007","volume":"36","author":[{"given":"Michael B.","family":"Rothberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"6567_CR1","doi-asserted-by":"publisher","unstructured":"Pan H, Peto R, Karim QA, et al. Repurposed antiviral drugs for COVID-19 \u2013interim WHO SOLIDARITY trial results. MedRxiv 2020.10.15.20209817 [Preprint]. 2020 [cited 2020 Nov 18]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.15.20209817v1 doi: https:\/\/doi.org\/10.1101\/2020.10.15.20209817","DOI":"10.1101\/2020.10.15.20209817"},{"key":"6567_CR2","doi-asserted-by":"crossref","unstructured":"Ison MG, Portsmouth S, Yoshida Y, et al. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2020;20(10):1204-14. Clinicaltrials.gov registration number: NCT02949011.","DOI":"10.1016\/S1473-3099(20)30004-9"},{"key":"6567_CR3","unstructured":"Clinicaltrials.gov [Internet]. Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza. Clinical Trial; [cited 2020 Nov 18]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03684044Clinicaltrials.gov Identifier: NCT03684044."},{"issue":"1","key":"6567_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/19390211.2013.859852","volume":"11","author":"C Ulbricht","year":"2014","unstructured":"Ulbricht C, Basch E, Cheung L, et al. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. Journal of dietary supplements. 2014;11(1):80-120.","journal-title":"Journal of dietary supplements."},{"issue":"2","key":"6567_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/147323000403200205","volume":"32","author":"Z Zakay-Rones","year":"2004","unstructured":"Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004;32(2):132-40.","journal-title":"J Int Med Res."},{"issue":"11","key":"6567_CR6","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s11606-020-06170-w","volume":"35","author":"M Macknin","year":"2020","unstructured":"Macknin M, Wolski K, Negrey J, Mace S. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial. J Gen Intern Med. 2020;35(11):3271-7. Clinicaltrials.gov registration number: NCT03410862.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"6567_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med. 2018;379(10):913-23. Clinicaltrials.gov resgistration number: NCT02954354.","journal-title":"N Engl J Med"},{"issue":"17","key":"6567_CR8","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1001\/archinte.161.17.2116","volume":"161","author":"M Zambon","year":"2001","unstructured":"Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med. 2001;161(17):2116-22.","journal-title":"Arch Intern Med."},{"issue":"10","key":"6567_CR9","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s11606-020-05640-5","volume":"35","author":"MB Rothberg","year":"2020","unstructured":"Rothberg MB, Martinez KA. Influenza Management via Direct to Consumer Telemedicine: an Observational Study. J Gen Intern Med. 2020;35(10):3111-3.","journal-title":"J Gen Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06567-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:48:26Z","timestamp":1642812506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06567-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6567"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06567-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he does not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}